Home > Publications database > Tempered signal strength via low-dose MEK inhibition optimizes therapeutic performance of engineered T cells. > Access to Fulltext
 
 
Main document file(s):
Similar records

DKFZ :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.7 | join2_v2601a
Maintained by zb.invenio@dkfz-heidelberg.de

Impressum | Data Privacy Policy